Beyond Inc to Acquire Buy Buy Baby Brand Rights Reuniting with Bed Bath Beyond Jim Cramers OnAir Silence Trumps 3700 Stock Trades Expose Potential Conflict of Interest Concerns Retail Closure Longstanding Chain Shuts Down After 33 Years of Business BP Chairman Abruptly Removed Amid Allegations of Bullying and Overbearing Conduct Ashram Life in Himalayan Foothills Wellness Tourism Sector May Offer Modest Economic Potential US Seeks to Expand AI Integration in Asia Following TrumpXi Talks James River Group Holdings Q1 2026 Earnings Missed Estimates Drive Modest Share Decline Satellos Bioscience Inc MSLE Q1 2026 Earnings NarrowerThanExpected Loss Marks Progress Amid PreRevenue Stage Outset Medical Inc OM Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges Atea Pharmaceuticals Q1 2026 Earnings Narrower Loss Surprises Analysts Amid RD Progress Entergy Corporation Q1 2026 Earnings Narrow EPS Miss Amidst Operational Stability BKV Q1 2026 Earnings EPS Misses Estimates as Revenue Details Remain Undisclosed Veris Residential VRE Hovers Near Support With Minimal Movement Fulcrum Therapeutics FULC Holds Steady Near Support Amid Biotech Sector Uncertainty GigaCloud Technology GCT Slips Slightly as It Consolidates Near Resistance Foxx Development Holdings FOXX Plunges 1574 Key Levels and Market Dynamics Pagaya Technologies Warrants PGYWW Climb 1255 as LowPriced Warrants Test Key 006 Level Yahoo Finance Releases Best Private Student Loans for May 2026 What Borrowers Should Know CompX International CIX Q1 2026 Earnings EPS of 048 Drives Stock Rally ASP Isotopes ASPI Surges 2486 Key Levels and Potential Drivers Rapid7 Q1 2026 Earnings EPS Surpasses Expectations Stock Rises Velocity Financial Q1 2026 Earnings EPS Beat Fails to Boost Stock BUD Q1 2026 Earnings EPS Beats Estimates by 815 Yet Shares Slip ALK Q1 2026 Earnings EPS Falls Short on Higher Costs Shares Rally on Demand Optimism KOSS Q1 2026 Earnings Loss Per Share Widens Amidst Challenging Retail Environment COHU Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amphastar Pharmaceuticals AMPH Q1 2026 Earnings EPS Misses Estimates by 416 as Stock Edges Higher